← Back to Search

Treatment for Charcot-Marie-Tooth Disease (INC-6602 Trial)

N/A
Recruiting
Led By Michael E Shy, MD
Research Sponsored by University of Iowa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once
Awards & highlights

Summary

This project includes two projects. One is looking for new genes that cause Charcot Marie Tooth disease (CMT). The other is looking for genes that do not cause CMT, but may modify the symptoms a person has.

Eligible Conditions
  • Charcot-Marie-Tooth Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once
This trial's timeline: 3 weeks for screening, Varies for treatment, and once for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Charcot Marie Tooth disease type 1A (CMT1A) gene modifiers
New genetic causes of CMT

Find a Location

Who is running the clinical trial?

Children's National Research InstituteOTHER
218 Previous Clinical Trials
256,860 Total Patients Enrolled
Seattle Children's HospitalOTHER
308 Previous Clinical Trials
5,227,633 Total Patients Enrolled
Massachusetts General HospitalOTHER
2,993 Previous Clinical Trials
13,229,671 Total Patients Enrolled
1 Trials studying Charcot-Marie-Tooth Disease
5,000 Patients Enrolled for Charcot-Marie-Tooth Disease
~137 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top